par Collet, L;Noël, J-C;Catteau, Xavier
;Ardin, Maude;Berthet, Justine;Ghamry-Barrin, Sarah;Treilleux, I;Bengrine Lefevre, Leïla;Martinez, M;Rothé, Françoise
;Sotiriou, Christos
;Caux, C;Dubois, B;Ray-Coquard, Isabelle;Le Saux, Olivia
Référence ESMO Open, 10, 6, page (105104)
Publication Publié, 2025-06-01



Référence ESMO Open, 10, 6, page (105104)
Publication Publié, 2025-06-01
Article révisé par les pairs
Titre: |
|
Auteur: | Collet, L; Noël, J-C; Catteau, Xavier; Ardin, Maude; Berthet, Justine; Ghamry-Barrin, Sarah; Treilleux, I; Bengrine Lefevre, Leïla; Martinez, M; Rothé, Françoise; Sotiriou, Christos; Caux, C; Dubois, B; Ray-Coquard, Isabelle; Le Saux, Olivia |
Informations sur la publication: | ESMO Open, 10, 6, page (105104) |
Statut de publication: | Publié, 2025-06-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | high-grade serous ovarian cancer |
immunotherapy | |
platinum-based chemotherapy | |
tumor microenvironment | |
tumor–stroma proportion | |
MeSH keywords: | Humans |
Female | |
Ovarian Neoplasms -- pathology -- drug therapy -- mortality | |
Prognosis | |
Middle Aged | |
Aged | |
Biomarkers, Tumor | |
Antibodies, Monoclonal, Humanized -- therapeutic use | |
Immunotherapy -- methods | |
Tumor Microenvironment | |
Adult | |
Stromal Cells -- pathology | |
Immune Checkpoint Inhibitors -- therapeutic use | |
Langue: | Anglais |
Identificateurs: | urn:issn:2059-7029 |
info:doi/10.1016/j.esmoop.2025.105104 | |
info:pii/S2059-7029(25)00973-1 | |
info:pmid/40472658 | |
PMC12172955 |